Jay Giri
Biographic Data
| ID | 8450044 |
|---|---|
| NAME | Jay Giri |
| GIVEN NAMES | Jay |
| FAMILY NAME | Giri |
| SIGNATURE | GIRI J |
| AFFILIATIONS | University of Pennsylvania |
| ORCID | 0000-0002-8076-0098 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
In this cohort study of US patients with T2D, GLP-1 RA use increased, but remained low overall for treatment of T2D, particularly among patients with ASCVD who are likely to derive the most benefit. Asian, Black, and Hispanic patients and those with low income were less likely to receive treatment with a GLP-1 RA. Strategies to lower barriers to GLP-1 RA use, such as lower cost, are needed to prevent the widening of well-documented inequities in …
No prominent works on this page.
Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
In this cohort study of US patients with T2D, GLP-1 RA use increased, but remained low overall for treatment of T2D, particularly among patients with ASCVD who are likely to derive the most benefit. Asian, Black, and Hispanic patients and those with low income were less likely to receive treatment with a GLP-1 RA. Strategies to lower barriers to GLP-1 RA use, such as lower cost, are needed to prevent the widening of well-documented inequities in …
Demography (1 work) · Demography (1 work) · Diabetes mellitus (1 work) · Diabetes Treatment and Management (1 work) · Endocrinology (1 work) · Environmental health (1 work) · Ethnic group (1 work) · Gastroesophageal reflux and treatments (1 work) · Gerontology (1 work) · Heart Failure Treatment and Management (1 work)